Martin Philpott

机构：Nuffield Orthopaedic Centre, University of Oxford, NIHR Oxford Musculoskeletal Biomedical Research Centre, Oxford BioMedica (United Kingdom) · ORCID：0000-0003-3632-0084

发表论文 173 篇 · 总被引 10112 次 · h-index 39

代表论文

• Correcting PCR amplification errors in unique molecular identifiers to generate accurate numbers of sequencing molecules (2024 · Nature Methods · 被引 42)
• BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma (2023 · Gastroenterology · 被引 29)
• The human milk oligosaccharide 3′sialyllactose reduces low-grade inflammation and atherosclerosis development in mice (2024 · JCI Insight · 被引 17)
• Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival (2023 · Cell Communication and Signaling · 被引 13)
• PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo (2024 · Scientific Reports · 被引 7)
• Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer (2025 · Experimental & Molecular Medicine · 被引 5)